GLAXOSMITH ended its 2021FY financial period on a positive note as its topline surged moderately by 5.42%YoY to NGN22.45bn (from NGN21.30bn in 2020FY). The topline expansion was spearheaded by growth in the Consumer Healthcare segment (+16.63%YoY) while the Pharmaceuticals Segment grew by 0.77%YoY to NGN15.16bn (vs NGN15.05bn in 2020FY). Hence, revenue stood at NGN22.45bn in 2021FY compared to NGN21.30bn in the previous financial period. In the first quarter of 2022, the firm also recorded an impressive expansion in topline. We note that the revenue performance in the quarter represents its highest quarterly revenue in 24 quarters (since Q1:2016).
You May Also Like
The Week in View – 22nd April 2022
- April 27, 2022
Dear All, Kindly click the link below to access our stock market report for today, 22nd April, 2022.…
Earnings Update – OKOMUOIL 2021FY Revenue Hits Record High
- April 8, 2022
Since the start of year 2021, Okomu Oil Palm Plc has ridden on price rally to drive strong…
Daily Stock market Report- 7th July 2021
- July 8, 2021
Kindly find attached our daily stock market report- 7th JDaily Stock Market Report for 7th July 2021uly 2021.
Earnings Update – DANGCEM 2021FY Staying on the Path of Growth
- April 8, 2022
Nothing takes us by surprise in the just released 2021FY financial scorecard of Dangote Cement Plc. Revenue performance…
The Week in View – Friday, 16th Dec 2022
- December 19, 2022
Kindly find attached The Week in View – 16th December 2022
Daily Stock Market Report – 11th May 2022
- May 11, 2022
Dear All, Kindly click the link below to access our stock market report for today, 11th May 2022.…